David Colleran

Insider Reports History

Entity
Individual
Location
600 Technology Park Drive, Suite 200, Billerica, MA
Signature
/s/ David Colleran
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Colleran:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Anika Therapeutics, Inc. EVP, General Counsel, Corp Sec Common Stock 33K $851K $25.79 Mar 11, 2024 Direct
Anika Therapeutics, Inc. EVP, General Counsel, Corp Sec Restricted Stock Unit 19.3K $499K $25.79 Mar 15, 2024 Direct
Anika Therapeutics, Inc. EVP, General Counsel, Corp Sec Stock Option (Right to Buy) 46.9K Mar 15, 2024 Direct

Insider Reports Filed by David Colleran

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANIK Anika Therapeutics, Inc. Mar 15, 2024 2 $0 4 Mar 19, 2024 EVP, General Counsel, Corp Sec
ANIK Anika Therapeutics, Inc. Mar 11, 2024 9 -$126K 4 Mar 12, 2024 EVP, General Counsel, Corp Sec
ANIK Anika Therapeutics, Inc. Mar 10, 2023 3 -$58.7K 4 Mar 14, 2023 EVP, General Counsel, Corp Sec
ANIK Anika Therapeutics, Inc. Mar 9, 2023 5 -$29.1K 4 Mar 10, 2023 EVP, General Counsel, Corp Sec
ANIK Anika Therapeutics, Inc. Mar 4, 2023 3 -$23.2K 4 Mar 7, 2023 EVP, General Counsel, Corp Sec
ANIK Anika Therapeutics, Inc. May 11, 2022 1 $32.1K 4 May 12, 2022 EVP, General Counsel, Corp Sec
ANIK Anika Therapeutics, Inc. Mar 14, 2022 1 $40K 4 Mar 16, 2022 EVP, General Counsel, Corp Sec
ANIK Anika Therapeutics, Inc. Mar 11, 2022 2 $0 4 Mar 15, 2022 EVP, General Counsel, Corp Sec
ANIK Anika Therapeutics, Inc. Mar 9, 2022 3 -$28.3K 4 Mar 11, 2022 EVP, General Counsel, Corp Sec
ANIK Anika Therapeutics, Inc. Mar 4, 2022 3 -$22.8K 4 Mar 7, 2022 EVP, General Counsel, Corp Sec